Cannabis & Botanicals
Terpene and cannabinoid profiling with selectivity beyond standard GC.
The cannabis and botanical extract industries demand precise terpene profiling and cannabinoid quantification under fast-evolving regulatory frameworks. Many target analytes are positional or stereo-isomers of one another — and conventional GC detection treats them as identical. GC-UV adds structural fingerprinting to existing workflows, supporting potency, authenticity, and product-development work simultaneously.
What conventional detection misses.
Terpene isomer profiling
α- and β-pinene, myrcene, ocimene isomers all influence product character and must be reported individually.
Cannabinoid neutral / acid forms
Decarboxylation behaviour and isomeric variants complicate potency reporting.
Pesticide and residual solvent screening
Regulatory panels expand each year; orthogonal confirmation reduces false positives.
How INSCAN resolves it.
- Resolve terpene and cannabinoid isomers by direct spectral comparison.
- Trace-level detection supports residual solvent and pesticide confirmation.
- Library extensibility for emerging cannabinoid analogues and minor terpenes.
- Terpene isomer resolution
- Baseline
- Residual solvent LOD
- ppb
- Library extensibility
- User-curated cannabinoids
What the lab actually does.
- STEP 01
Sample preparation
Solvent extraction or SPME from flower, concentrate, or finished product.
- STEP 02
GC separation
Standard cannabinoid and terpene methods.
- STEP 03
UV identity
Spectral confirmation per analyte, isomer-resolved.
- STEP 04
Compliance reporting
Outputs aligned with state, EU, and Health Canada frameworks.
Typical applications.
- Terpene profiling for product characterisation
- Cannabinoid potency and acid-form quantitation
- Residual solvent confirmation in concentrates
- Pesticide screening secondary identification
- Botanical extract authentication and QA
The right INSCAN for Cannabis & Botanicals.
Talk to us about Cannabis & Botanicals.
Application notes, sample testing, and integration discussions for licensing, co-development, and OEM partners.
